Scientists find new marker that predicts early recurrence of breast cancer

A multi-institutional team led by scientists from the Medical College of Wisconsin (MCW) Cancer Center has discovered PD-L2 as a therapy-relevant marker to identify patients with estrogen receptor-positive breast cancer who may benefit from new immunotherapies.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup